We found that anemia and thymus atrophy were significantly exacerbated in Apcmin/+Mlkl-/- mice compared to Apcmin/+littermate controls, suggesting that loss of MLKL increased intestinal tumor development (Figure 2G, 2H). Here, MLKL is linked to intestinal neoplasm.